Compound Evidence File
#EC-2026-0020
Anadrol Oil
Filed under Injectable Oils. The bureau holds 97 laboratory returns for this compound from 35 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
35 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 10.0 | 10.0 | 20 Jan 2026 | 4 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 11 Apr 2026 | 5 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 19 Jun 2026 | 4 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 17 Apr 2026 | 21 May 2026 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 | 27 Feb 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 28 Apr 2026 | 6 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 9.9 | 23 Mar 2026 | 22 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 9.9 | 6 May 2026 | 12 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 9.9 | 9.9 | 10.0 | 12 Jan 2026 | 7 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 9.9 | 9.9 | 10.0 | 4 Jan 2026 | 20 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 10.0 | 14 May 2026 | 4 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Dec 2025 | 11 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Mar 2026 | 4 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 15 Jan 2026 | 4 Jun 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 8.9 | 7.8 | 9.9 | 23 May 2026 | 23 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 8.7 | 7.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 1 | 8.6 | 8.6 | 8.6 | 8 Jul 2025 | 8 Jul 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.1 | 6.9 | 9.4 | 23 May 2026 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 7.8 | 7.1 | 8.8 | 24 May 2026 | 24 May 2026 |
| HealthTide BiotechCASE #VI-2026-0955 | X | 1 | 7.8 | 7.8 | 7.8 | 13 Feb 2025 | 13 Feb 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 7.5 | 6.5 | 8.4 | 24 May 2026 | 24 May 2026 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 1 | 6.9 | 6.9 | 6.9 | 7 May 2025 | 7 May 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 6.9 | 6.9 | 6.9 | 13 Feb 2025 | 13 Feb 2025 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 6.7 | 6.7 | 6.7 | 6 May 2025 | 6 May 2025 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 6.4 | 6.4 | 6.4 | 13 Jun 2025 | 13 Jun 2025 |
| UtherCASE #VI-2026-0902 | X | 4 | 6.2 | 4.8 | 7.6 | 3 Jun 2025 | 17 May 2026 |
| ZhuoYan labCASE #VI-2026-0902 | X | 3 | 6.2 | 6.1 | 6.2 | 21 May 2025 | 23 May 2026 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 2 | 5.4 | 3.8 | 7.0 | 8 Jul 2025 | 26 Jan 2026 |
| NexaphCASE #VI-2026-0944 | X | 5 | 5.0 | 3.5 | 7.4 | 25 Apr 2025 | 24 May 2026 |
| Coastal PeptidesCASE #VI-2026-0958 | X | 1 | 4.3 | 4.3 | 4.3 | 13 Feb 2025 | 13 Feb 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 3.5 | 3.5 | 3.5 | 25 Apr 2025 | 25 Apr 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.7 | 0.7 | 0.7 | 3 Jul 2025 | 3 Jul 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 0.4 | 0.4 | 0.4 | 25 Apr 2025 | 25 Apr 2025 |
Open any subject to view the batch-level evidence for Anadrol Oil alone.